Skip to main content
Figure 3 | BMC Medical Genomics

Figure 3

From: A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone

Figure 3

Cardiac transcriptome analysis. Relationship between fasting plasma glucose concentration and heart weight (A), Venn-diagrams showing overlap in the total number of differentially expressed genes (B) and PPARγ target genes (C) in cardiac tissue in HF + Rosi and HF + Pio groups relative to HF-diet control group (P < 0.01). Graphical representation (D) of significantly enriched Biological Processes in HF + Rosi and HF + Pio treatment groups relative to HF-diet control group. Bars display a selection of significantly enriched biological processes (-log10 (p-value)) modulated by HF + Rosi (dark bars) or HF + Pio (light bars).

Back to article page